140 related articles for article (PubMed ID: 15507528)
21. Natural killer cells inhibit outgrowth of autologous Epstein-Barr virus-infected B lymphocytes.
Kaplan J; Shope TC
Nat Immun Cell Growth Regul; 1985; 4(1):40-7. PubMed ID: 2993873
[TBL] [Abstract][Full Text] [Related]
22. Antigen presentation by EBV-B cells to resting and activated T cells: role of interleukin 1.
Chu ET; Lareau M; Rosenwasser LJ; Dinarello CA; Geha RS
J Immunol; 1985 Mar; 134(3):1676-81. PubMed ID: 2981918
[TBL] [Abstract][Full Text] [Related]
23. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
[TBL] [Abstract][Full Text] [Related]
24. The immune modulation of B-cell responses by Porphyromonas ginginvalis and interleukin-10.
Champaiboon C; Yongvanitchit K; Pichyangkul S; Mahanonda R
J Periodontol; 2000 Mar; 71(3):468-75. PubMed ID: 10776936
[TBL] [Abstract][Full Text] [Related]
25. Histamine is a potent inducer of IL-18 and IFN-gamma in human peripheral blood mononuclear cells.
Kohka H; Nishibori M; Iwagaki H; Nakaya N; Yoshino T; Kobashi K; Saeki K; Tanaka N; Akagi T
J Immunol; 2000 Jun; 164(12):6640-6. PubMed ID: 10843724
[TBL] [Abstract][Full Text] [Related]
26. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
[TBL] [Abstract][Full Text] [Related]
27. Truncated Escherichia coli thioredoxin induces proliferation of human blood mononuclear cells and production of reactive oxygen species as well as proinflammatory cytokines.
Liu SY; Liu IC; Lin TY
Cell Biochem Funct; 2016 Jun; 34(4):226-32. PubMed ID: 27029462
[TBL] [Abstract][Full Text] [Related]
28. Cord blood mononuclear cell transformation assay for screening for the presence of Epstein-Barr virus.
Lucas KG; Burton R; Heilman DK; Pollok K; Emanuel D
J Hematother; 1997 Dec; 6(6):587-90. PubMed ID: 9483194
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-specific cytokine-induced killer cells for treatment of Epstein-Barr virus-related malignant lymphoma.
Pfeffermann LM; Pfirrmann V; Huenecke S; Bremm M; Bonig H; Kvasnicka HM; Klingebiel T; Bader P; Rettinger E
Cytotherapy; 2018 Jun; 20(6):839-850. PubMed ID: 29754771
[TBL] [Abstract][Full Text] [Related]
30. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
Tosato G; Magrath IT; Blaese RM
J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
[TBL] [Abstract][Full Text] [Related]
31. Interferon production by Epstein-Barr virus in human mononuclear leukocytes.
Kikuta H; Mizuno F; Yano S; Osato T
J Gen Virol; 1984 Apr; 65 ( Pt 4)():837-41. PubMed ID: 6323626
[TBL] [Abstract][Full Text] [Related]
32. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.
Sun Q; Burton RL; Pollok KE; Emanuel DJ; Lucas KG
Cell Immunol; 1999 Aug; 195(2):81-8. PubMed ID: 10448007
[TBL] [Abstract][Full Text] [Related]
33. Role of 4-1BB (CD137) in the functional activation of cord blood CD28(-)CD8(+) T cells.
Kim YJ; Brutkiewicz RR; Broxmeyer HE
Blood; 2002 Nov; 100(9):3253-60. PubMed ID: 12384425
[TBL] [Abstract][Full Text] [Related]
34. The interleukin-10 homolog encoded by Epstein-Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responses.
Stewart JP; Rooney CM
Virology; 1992 Dec; 191(2):773-82. PubMed ID: 1333123
[TBL] [Abstract][Full Text] [Related]
35. Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers.
Zou JP; Morford LA; Chougnet C; Dix AR; Brooks AG; Torres N; Shuman JD; Coligan JE; Brooks WH; Roszman TL; Shearer GM
J Immunol; 1999 Apr; 162(8):4882-92. PubMed ID: 10202033
[TBL] [Abstract][Full Text] [Related]
36. IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon gamma.
Thyphronitis G; Tsokos GC; June CH; Levine AD; Finkelman FD
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5580-4. PubMed ID: 2546158
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F
Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728
[TBL] [Abstract][Full Text] [Related]
38. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
39. Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells.
Chu E; Umetsu D; Lareau M; Schneeberger E; Geha RS
Eur J Immunol; 1984 Apr; 14(4):291-8. PubMed ID: 6327319
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.
Harrop JA; Reddy M; Dede K; Brigham-Burke M; Lyn S; Tan KB; Silverman C; Eichman C; DiPrinzio R; Spampanato J; Porter T; Holmes S; Young PR; Truneh A
J Immunol; 1998 Aug; 161(4):1786-94. PubMed ID: 9712045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
